Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective

Nassib Abou Heidar, Omar Chehab, Rami Z. Morsi, Joseph Elias, Christopher El Mouhayyar, Amjad Kanj, Mustafa Ajam, Abdallah Haykal, Mohit Pahuja, Habib Dakik, Diane Levine, Nashat Imran, Aiden Abidov

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Data on the epidemiology of cardiovascular diseases (CVD) in patients with autosomal dominant polycystic kidney disease (ADPKD) are limited. In this study, we assess the prevalence of CVD in patients with ADPKD and evaluate associations between these two entities. Methods: Using the National Inpatient Sample database, we identified 71,531 hospitalizations among adults aged ≥ 18 years with ADPKD, from 2006 to 2014 and collected relevant clinical data. Results: The prevalence of CVD in the study population was 42.6%. The most common CVD were ischemic heart diseases (19.3%), arrhythmias (14.2%), and heart failure (13.1%). The prevalence of CVD increased with the severity of renal dysfunction (RD). We found an increase in hospitalizations of patients with ADPKD and CVD over the years (ptrend < 0.01), irrespective of the degree of RD. CVD was the greatest independent predictor of mortality in these patients (OR: 3.23; 95% CI 2.38–4.38 [p < 0.001]). In a propensity matched model of hospitalizations of patients with CKD with and without ADPKD, there was a significant increase in the prevalence of atrial fibrillation/flutter (AF), pulmonary hypertension (PHN), non-ischemic cardiomyopathy (NICM), and hemorrhagic stroke among patients with ADPKD when compared to patients with similar degree of RD without ADPKD. Conclusions: The prevalence of CVD is high among patients with ADPKD, and the most important risk factor associated with CVD is severity of RD. We found an increase in the trend of hospitalizations of patients with ADPKD associated with increased risk of AF, PHN, NICM, and hemorrhagic stroke. History of CVD is the strongest predictor of mortality among patients with ADPKD.

Original languageEnglish (US)
JournalClinical and Experimental Nephrology
DOIs
StateAccepted/In press - 2022
Externally publishedYes

Keywords

  • Autosomal dominant polycystic kidney disease
  • Cardiovascular disease
  • Chronic kidney disease
  • Mortality

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective'. Together they form a unique fingerprint.

Cite this